论文部分内容阅读
目的：分析鼻腔非何杰金淋巴瘤（NHL）治疗方法和疗效。方法：1975年6月～1993年3月收治30例鼻腔NHL。单纯放疗16例，综合治疗（放疗＋化疗）14例。照射剂量：＜45Gy15例，≥45Gy15例。结果：全组5年生存率为70．8％（17／24）。病变局F民于鼻腔和超出鼻腔组的5年生存率分别为85．7％和50．0％。单纯放疗组和放疗＋化疗组的5年生存率分别为57．1％和90．0％。照射剂量＜45Gy和≥45Gy的5年生存率分别为64．3％和80．0％。建议：病变局限于鼻腔者不必做颈部预防性照射。对病变超出鼻腔或有区域淋巴结受侵者，应采用放疗与化疗综合治疗。
Objective: To analyze the treatment and efficacy of nasal non-Hodgkin’s lymphoma (NHL). Methods: From June 1975 to March 1993, 30 cases of nasal NHL were treated. Radiotherapy alone in 16 cases, comprehensive treatment (radiotherapy + chemotherapy) in 14 cases. Irradiation dose: <45Gy15 cases, ≥45Gy15 cases. Results: The 5-year overall survival rate was 70.8% (17/24). The 5-year survival rates of patients with F in the nasal cavity and beyond the nasal cavity were 85.7% and 50.0% respectively. The 5-year survival rates of radiotherapy alone group and radiotherapy + chemotherapy group were 57.1% and 90.0%, respectively. The 5-year survival rates of irradiated dose <45Gy and ≥45Gy were 64.3% and 80.0% respectively. Recommendation: limited to the nasal pathology who do not have to do neck prophylaxis. On lesions beyond the nasal cavity or regional lymph nodes were invaded, radiotherapy and chemotherapy should be used comprehensive treatment.